Research Article | | Peer-Reviewed

Phytochemical Screening and Antimicrobial Properties of Leaf Extracts from Newbouldia laevis (P. Beauv) and Flueggea virosa (Roxb. ex Willd.)

Received: 3 March 2025     Accepted: 18 March 2025     Published: 2 April 2025
Views:       Downloads:
Abstract

Using plants to treat human diseases is very old and has evolved throughout human history. Flueggea virosa and Newbouldia laevis are two plant species acclimatized in Benin and used in Africa to treat several diseases such as malaria, liver diseases; fever, migraine, diarrhea, dysentery, intestinal worms, diabetes, sexually transmitted diseases, etc. In this work, we studied methanolic and hydroethanolic leaf extracts from those species. Phytochemical screening was determined by the Hounton and Raman methods, and the antimicrobial activity of the leaf extracts was evaluated by the microdilution method. The antimicrobial properties of the leaf extracts were examined on five bacteria strains. The phytochemical analysis revealed the presence of alkaloids, polyphenols, tannins, flavonoids, anthocyanins, coumarins, mucilages, reducing compounds, and bound anthracene derivatives (O-heterosides and C-heterosides). Quinonine derivatives were absent in the leaves of Flueggea virosa, but present in the leaves of Newbouldia laevis. In addition, the leaves of Flueggea virosa contained saponosides, triterpenoids compared to those of Newbouldia laevis. Moreover, Flueggea virosa leaves enclosed no cardenolides, cyanogenic derivatives as well as, free leuco-anthocyanins and anthracene derivatives. Evaluation of antimicrobial activity in the five strains included in this study showed better results (minimum inhibitory concentrations between 31.2 and 1000 μg/mL), specifically with the methanolic extract from Flueggea virosa leaves that showed a Minimum Inhibitory Concentration (MIC) equal to 31.2 μg/mL against the reference strain of Staphylococcus aureus ATCC 12600. Among the two plants, Flueggea virosa extracts showed more interesting antimicrobial activity then those of Newbouldia laevis on strains.

Published in Science Journal of Chemistry (Volume 13, Issue 2)
DOI 10.11648/j.sjc.20251302.11
Page(s) 33-40
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.

Copyright

Copyright © The Author(s), 2025. Published by Science Publishing Group

Keywords

Flueggea virosa, Newbouldia laevis, Phytochemical Screening, Antimicrobial Activity

1. Introduction
Plants have proved to be one of the major sources of primary health care in developing countries . In Benin, several ethnobotanical surveys reveal the effectiveness of plants in treating some illnesses. Among those plant species, Flueggea virosa (Roxb. ex Willd.) Euphorbiaceae and Newbouldia laevis (P. Beauv) Bignoniaceae play great roles. Thus, they are used in traditional medicine for the treatment of diverse diseases using several methods for preparation. Leaf and root decoctions of Flueggea virosa are applied against liver diseases , cough . Flueggea virosa leaf infusion is used for the treatment of diarrhea stomachaches , as well as in the treatment of sexual impotence and erection dysfunction. Leaves and roots crushed or decocted treat infertility problems in women . Leafy stem decoction is used in the treatment of diabetes in pregnant women . The decocted leaves of Newbouldia laevis are also used against different types of ulcers, hemorrhoids and constipation . These plants are also useful in the treatment of ear and chest pains, epilepsy and convulsions affecting children. Several studies have shown the application of plants in traditional and modern medicine systems. They are particularly the richest source of medicine utilized by local populations in Africa, Asia and Latin America . Some previous reports showed that N. laevis possesses antibacterial , antiplasmodial, anthelmintic in vitro and antiradical activities. Flueggea virosa presented also in previous studies antiplasmodial activities . F. virosa is also an important medicinal plant in tropical Africa, used alone or in combination with other plants, for a variety of purposes, including liver, kidney, urinary and venereal diseases, bile deficiency, testicular inflammation, frigidity, sterility, heavy menstruation, rheumatism and arthritis. The plant has been around for a long time . According to the WHO in 2022, 7.7 million people die each year from bacterial infections . Therefore, the present investigation reported here focused on the phytochemical screening and antimicrobial activity of the methanolic and hydroethanolic extracts of these two medicinal plant species.
2. Material and Methods
2.1. Chemicals Used
The ethanol (95%) and methanol used for extraction were produced by ADER-Cameroon. Distilled water was obtained from POBEL DETA (made in Spain) and used as a hydroalcoholic extraction solution. The resulting filtrate from the extraction was concentrated using the Heidolph rotavapor (water bath). Microbial strains were cultured on agar to confirm their identity and kept in tilted Msouculler Hinton agar in a test tube. Strains were then reactivated for 24 hours at 37°C used each test.
2.1.1. Plant Material
The plant material consisted of leaves from Flueggea virosa (Roxb. ex Willd.) Euphorbiaceae and Newbouldia laevis (P. Beauv) Bignoniaceae (Figures 1 and 2) harvested respectively in Parana and Djadjo, located in the municipality of Abomey-Calavi (Atlantic Department) in the Southern Benin Republic on 20 December 2022 and 09 January 2023 and was dried at room temperature in the Laboratory of Physics Organic Chemistry and Synthesis (LaCOPS) of the University of Abomey-Calavi (UAC). Both species were identified, certified and authenticated by the National Herbarium with specimens N° YH1060/HNB and N° YH1061/HNB at the UAC National Source Herbarium.
Figure 1. Flueggea virosa leaves, flowers and stems.
Figure 2. Newbouldia laevis leaves, flowers and stems.
2.1.2. Process for Obtaining the Plant Leaf Powder
The dried leaves were ground to a fine powder using a blender, and the resulting powder was used later for the preparation of extracts.
2.1.3. Preparation of the Leaf Extracts
The methanolic extracts were prepared by maceration of 2.5 kg and 1.5 kg of dried leaf powder of F. virosa and N. laevis, respectively in 18 L and 10 L of methanolic solvent and left for extraction during 72 hours. After filtration using filter paper, the extract obtained was concentrated using a rotary evaporator at 55°C. The raw extracts were then dried in the oven at 48°C. The extract’s weight was measured with accuracy. The hydroethanolic extract was obtained by macerating 50 g of the leaf powder from plants for 72 hours in 500 mL of a 70/30 (V/V) ethanol-water mixture. The resulting extract, which was concentrated with a rotary evaporator, was dried at 50°C and weighted with precision.
2.2. Phytochemical Screening of Leaf Powder from N. laevis and F. virosa
Phytochemical screening is one of the techniques used for identifying the different major chemical groups contained in a plant organ. This technique is based on coloration and precipitation reactions that allow the detection of chemical families in the powders using the Houghton and Raman method adapted to our laboratory condition .
2.3. Strains Used
Five bacterial strains were used. These are the bacterial strains of reference: (Gram-positive): Enterococcus faecalis ATCC 51299, Staphylococcus aureus ATCC 12600, and (Gram-negative): Klebsiella pneumoniae NR 4188, Escherichia Coli ATCC 25922 and finally a clinical strain: Salmonella typhimirim STM CPC.
2.3.1. Preparation of Stock Solutions
The extract stock solutions were prepared at 10 mg/mL by dissolving 10 mg of extract powder in 1 mL of DMSO 10%. The stock solutions of ciprofloxacin (Gibco, China) used as a positive control for strain testing were prepared under the same conditions at 1 mg/mL by dissolving 1 mg of powder from each plant organ in 1 mL of acidified distilled water .
The assessment of antibacterial activity was carried out using liquid microdilution methods. The antimicrobial activity study was evaluated by testing the sensitivity of extracts on bacterial strains. Activity indicators were determined, namely the Minimum Inhibitory Concentrations (MIC) as shown below.
2.3.2. Methods for the Evaluation of Antimicrobial Activities
(i). Preparation of Bacterial Suspension
For the bacterial suspension preparation, two decimal dilutions were made. Indeed, in 900 μL of sterilized distilled water, 100 μL of the bacterial strain suspension enriched in nutrient broth was added. The mixture is vortex-stirred for a seconds. This was the first decimal dilution. From this first dilution, 100 μL was taken and supplemented with 900 μL of sterilized distilled water. The whole was stirred in a vortex for a few seconds. This was the second decimal dilution. The latter was used for the flood of Petri dishes.
(ii). Evaluation of Antibacterial Activity
The antibacterial activities of the leaf extracts were evaluated by determining the minimum inhibitory concentrations (MIC) using the liquid micro-dilution method. The antimicrobial activity study was estimated by testing the sensitivity of extracts on bacterial strains. Activity indicators were determined, namely the Minimum Inhibitory Concentrations (MIC).
(iii). Determination of the Minimum Inhibitory Concentrations
Minimum inhibitory concentrations of the selected samples were determined using 24-hour young colony technique. In this method, 50 μL sterile MH broth was distributed in the 96 wells of the microplate except for the first line. A volume of 50 μL of the extract stock solution were then added to the first two columns of the microplate. Two from the first well on the second line to the last well of the line were diluted; 50 μL inoculum was distributed into all wells. The microplate was then incubated for 24 hours at 37°C. Afterward, 20 μL of 0.01% INT was in the 96 wells and then; re-incubated for 30 minutes at 37°C. The test was read. Wells that turn pink indicate bacterial growth. MIC in the first well was not pink-coloured.
3. Results
3.1. Yield of Extract
The extraction yield (r) was calculated using the mass of raw extract obtained (mEx) for a given mass of the powder (mp) as related in the equation below:
r=mEXmp×100
The results obtained on each plant extract and according to the solvent used as well as some physical characteristics are presented in Table 1 below.
Table 1. Yield and appearance of methanol and hydroethanol extracts from the leaves of F. virosa and N. laevis.

Plants

Extracts

Yields (%)

Color

Physical aspect

Flueggea virosa

Methanolic

8.84

Brown

Paste

Ethanol/Water (70/30)

10.85

Green

Powder

Newbouldia laevis

Methanolic

5.2

Black

Powder

Ethanol/Water (70/30)

8.5

Green

Powder

3.2. Chemical Composition of Flueggea virosa and Newbouldia laevis
Table 2. Phytochemical screening of leaves powders from Flueggea virosa and Newbouldia laevis.

Active Ingredient Class

Flueggea virosa leaves

Newbouldia laevis leaves

Alkaloids

+

+

Polyphenols

+

+

Tannins

+

+

catechin tannins

+

+

gallic tannins

+

+

flavonoids (flavones)

+

+

anthocyanins

+

+

leuco anthocyanins

-

-

quinonic derivatives

-

+

saponins

+

-

triterpenes

+

-

cardenolides

-

-

cyanogenic derivatives

-

-

mucilages

+

+

coumarins

+

+

reducing compounds

+

+

free anthracene derivatives

-

-

anthracenic O-heterosides

+

+

anthracenic C-heterosides

+

+

+: present in the leaf –: absent in the leaf
Table 2 presents the phytochemical screening of Flueggea virosa and Newbouldia laevis. This analysis revealed severals metabolites in the extracts.
3.3. Antibacterial Activities of F. virosa and N. laevis
The biological activity obtained from the extracts of these plants are presented in Table 3.
Table 3 showed that, apart from the hydroethanolic extract which was not active on the strain E. faecalis ATCC 51299, all other extracts of Flueggea virosa were active on all five strains.
Table 3. Minimum inhibitory concentrations (MIC in μg /mL) of F. virosa and N. laevis in five strains, including 04 reference strains and one clinical strain.

Name of the plant

Sample code

E. coli ATCC 25922

K. pneumoniae NR 4188

S. typhimirim STM CPC

S. aureus ATCC 12600

E. faecalis ATCC 51299

Positive control

Ciprofloxacin

0.34

0.66

0.33

0.32

0.62

F. virosa

FVH

500

500

1000

250

NA

FVM

250

1000

500

31.2

500

N. laevis

NLH

1000

NA

NA

1000

NA

NLM

500

NA

NA

250

NA

FVM: Metanolic extract of Flueggea virosa, FVH: Hydroethanolic extract of Flueggea virosa, NLM: Methanolic extract of Newbouldia laevis, NLH: Hydroethanolic extract of Newbouldia laevis.
According to the classification criteria of Kuete and Efferth , extracts and fractions presented: high activity when MIC is between 0 and 100 μg/mL; moderate (100 < MIC < 625 μg/mL) and low or no (MIC > 625 μg/mL).
The best activity of the methanolic extract was achieved at 31.2 μg /mL with a minimum inhibitory concentration (MIC) against S. aureus strain ATCC 12600. The hydroethanolic extract had moderate activity on the growth of bacterial strains.
4. Discussion
Based on the results of the yield obtained in Table 1, the extraction yield for Flueggea virosa and Newbouldia laevis is considerable. The efficiency of hydroethanol extraction (10.85%) and (8.5%) is better than that of methanolic extraction (8.84%) and (5.2%), respectively. The solvent ethanol/water (70:30, V/V) is more polar than methanol. This variation in yield is explained by the influence of the polarity of the extraction solvent on those different leaves. Similar results were obtained by Oghenemaro et al. (2021), who reported 10.3% for the yield of the ethanolic extract of the leaves of F. virosa . Different results were obtained with another report , from the soxhlet-based methanolic extraction of F. virosa leaves which led to a yield of 26.34%, on the one hand, and with those of Bothon et al , during the aqueous and hydroethanol extraction of Newbouldia laevis that permitted the obtention of 6.03% and 5.23% respectively. The difference observed when compared with the results presented here could be explained by the time, the provenance of the plant materials, as well as the difference in solvent applied and the method used during extractions.
In our study, it was noted that different extracts presented alkaloids, tannins, flavonoids, anthocyanins, coumarins, mucilages, reducing compounds, anthracene derivatives (O-heterosides and C-heterosides), and a total absence of cardenolides, cyanogenic derivatives, leuco anthocyanins and anthracene free derivatives. It should be noted that this test revealed the presence of terpenoids and saponosides in the leaves of Flueggea virosa. They are not detected in the leaves of Newbouldia laevis. No quinonic derivatives were observed either in the leaves of Flueggea virosa or those of Newbouldia laevis. Our results are different from those obtained by Bothon et al., (2014) in the phytochemical screening of N. laevis leaves . These authors reported the presence of alkaloids, saponins, anthocyanins and tannins in this plant. Our results are similar to those reported by Udeozo and colleagues who showed the presence of flavonoids, tannins, terpenes, steroids and alkaloids. The results of Usman and Osuji for the N. laevis screening are different from those concerning saponins and anthocyanins. Our results justified partly those obtained by Tinnèlo et al. , during the phytochemical analysis of aqueous and hydroethanolic extracts of F. virosa leaves. There was the absence of alkaloids, reducing compounds, cardiotonic glycosides, cyanogenic derivatives, and C-heterosides in the extracts as previously proved by Traoré et al. .
The differences in these results when compared to earlier findings could be explained using the location (where the plant materials have been collected), period of collection, or the sensitivity of the screening method. Our results might justify the frequent use of these plants as a health remedy in traditional medicine. They could find applications in the manufacture of antibiotics after their toxicological studies.
In pharmacological screening, the hydroethanolic extract presented had moderate activity efficiency on the bacterial growth of strains . Extracts from N. laevis did not show any activity on K. pneumoniae NR 4188, E. faecalis ATCC 51299 and S. typhimirim STM CPC, but presented low activities, with hydroethanolic extract and moderated with methanolic extract on E. coli and S. aureus strains with MIC equal to 1000, 500 and 250 μg/mL of the respective extracts. The methanolic extract of N. laevis leaves was most active on the strains. Various research has been conducted on the antimicrobial activity of this plant species, revealing its ability to control a wide range of bacterial, fungal and sometimes parasitic strains.
Some of the previous studies have shown the antibacterial activity of these two plant species. In 2008, Usman and Osuji evaluated the antimicrobial activity of ethanol extract from Newbouldia laevis leaves in Nigeria. Their work has demonstrated interesting antibacterial activities against Escherichia coli, Klebsiella pneumonia and Salmonella typhi with MIC = 1563; 1563 and 3125 μg/mL respectively. These MICs compared to those from our study are high, so we can assume that our hydroethanolic and methanolic extracts of N. laevis are more active than the one from ethanol. The same comment could be made with the results of leaf extract activities of Flueggea virosa in our study, compared to those of the work of Osuagwu and Akomas on E. coli, S. typhimirim, Shigella flexneri and K. pneumonia . The MIC was high and respectively equaled to: 4000; 3500; 1250 and 1750 μg/mL except for S. flexneri which wasinhibited by the same concentration as Shigella sp in the present study. These observations could be explained by the fact that aqueous and hydroethanolic extracts are richer in bioactive substances (flavonoids, tannins, saponins, phenols) than the ethanolic extract F. virosa was the most active, including chloroform extract derived from root bark, which was found to be active against 13 microorganisms tested but with varying degrees of activity .
In vitro study by Okagu et al. reported that N. laevis hydroethanolic bark extract showed moderate activity against some bacterial species with minimum inhibitory concentrations (MIC) of 25000; 12500; 25000; 25000; 6250 and 25000 μg/mL, respectively on S. typhi, S. aureus, S. pneumoniae, B. subtilis, K. pneumoniae and P. aeruginosa. These MICs are higher than in our study. Overall, in this study, we noticed that the extracts of the leaves of F. virosa are more active on the five strains studied than those of N. laevis. Gram-negative bacteria showed a more pronounced sensitivity (good activity on S. aureus strain ATCC 12600) to the extracts of F. virosa while the extracts of N. laevis are less active with low or no activities.
From the above, this work focused on the two plant species and showed the significant chemical composition of the extracts studied and great significant antibacterial activities on certain strains, and then this work would partly justify their use by the population.
5. Conclusions
The main objective of this work is to contribute to valorization of traditional medicine through a phytochemical and biological study of F. virosa and N. laevis leaves, the Beninese medicinal plants. Methanol and hydroethanol extracts from leaves of the plants were prepared to assess their antimicrobial activities. To get an idea of the secondary metabolites present in the extract that could be responsible for the observed biological activities, a phytochemical screening of the leaf powder was performed. According to the results, the extracts from our study focused on methanolic and hydroethanolic extracts of the leaves of Flueggea virosa and Newbouldia laevis. The work showed that the four extracts studied are rich in phytochemical compounds such as total polyphenols, flavonoids, tannins, alkaloids, saponins, etc. Some metabolites are present or not in a given plant species and absent in the other. Some were absent in both plants. The extracts of the leaves of F. virosa are more active on strains studied than those of N. laevis. The presence of several common and varied metabolites is responsible for the interesting antimicrobial properties observed and constitutes a therapeutic potential in several areas, especially in traditional medicine. However, more in-depth research such as the study of active fractions as well as isolated compounds, active ingredients, and the determination of larval toxicity tests, acute toxicity, lethal doses, etc. are essential to validate their effectiveness and assurance in their general use.
Abbreviations

NA

Not Active

FVM

Methanolic Extract of Flueggea virosa

FVH

Hydroethanolic Extract of Flueggea virosa

NLM

Methanolic Extract of Newbouldia laevis

NLH

Hydroethanolic Extract of Newbouldia laevis

Acknowledgments
The authors express their gratitude the YaBiNaPA project for supporting this work.
Author Contributions
Noudamadjo Amandine: Funding acquisition, Investigation, Methodology, Writing – original draft.
Kpadonou-Kpoviessi Bénédicta: Methodology, Formal Analysis, Writing – original draft.
Glinma Bienvenu: Conceptualization, Formal Analysis, Writing – original draft, Validation, Supervision.
Goueti Basile: Investigation, Methodology.
Kampa-Kuemkon Blandine: Methodology, Visualization
Gbaguidi Ahokanou Fernand: Validation, Resources, Visualization.
Kpoviessi Dossou Sika Salomé: Project administration, Formal Analysis, Investigation.
Conflicts of Interest
The authors declare no conflicts of interest.
References
[1] Kpabi, I., Agban, A., Hoekou, Y., Pissang, P., Tchacondo, T., Batawila, K. Etude Ethnobotanique des Plantes à Activités Antiparasitaires Utilisées en Médecine Traditionnelle dans la Préfecture de Doufelgou au Nord du Togo. Journal of Applied Biosciences, 2020, 148, 15176-15189.
[2] Kpodar, M. S., Karou, S. D., Katawa, G., Anani, K., Gbekley, H. E.; Adjrah, Y.; Tchacondo, T.; Batawila, K.; Simpore, J. An Ethnobotanical Study of Plants Used to Treat Liver Diseases in the Maritime Region of Togo. Journal of Ethnopharmacology, 2016, 181, 263–273.
[3] Burkill, H. M. Entry for Lasiurus hirsutus (Forssk.) Boiss. [family POACEAE]. In: The useful plants of west Tropical Africa, 2nd edition. Royal Botanic Gardens, Kew, UK. 1985.
[4] Amri, E., Kisangau, D. P. Ethnomedicinal Study of Plants Used in Villages around Kimboza Forest Reserve in Morogoro, Tanzania. Journal of Ethnobiology and Ethnomedicine, 2012, 8(1), 1.
[5] Kamatenesi, M. M., Acipa, A., Oryem-Origa, H. Medicinal Plants of Otwal and Ngai Sub Counties in Oyam District, Northern Uganda. Journal of Ethnobiology and Ethnomedicine, 2011, 7(1), 7.
[6] Tugume, P., Kakuidi, E. K., Buyinza, M., Namaalwa, J., Kamatenesi, M., Mucunguzi, P., Kalema, J. Ethnobotanical Survey of Medicinal Plant Species Used by Communities around Mabira Central Forest Reserve, Uganda. Journal of Ethnobiology and Ethnomedicine, 2016, 12 (1), 5.
[7] Fah, L., Klotoé J. R., Dougnon V., Koudokpon H., Fanou, V. B. A., Dandjesso, C., Loko, F. Étude Ethnobotanique des Plantes Utilisées dans le Traitement du Diabète Chez Les Femmes Enceintes à Cotonou et Abomey-Calavi (Bénin). Journal of Animal &Plant Sciences, 2013, 18, 2647–2658.
[8] Komlaga, G., Agyare, C., Dickson, R. A., Mensah, M. L. K., Annan, K., Loiseau, P. M., Champy, P. Medicinal Plants and Finished Marketed Herbal Products Used in the Treatment of Malaria in the Ashanti Region, Ghana. Journal of Ethnopharmacology, 2015, 172, 333–346.
[9] Ouro-Djeri, H., Koudouvo, K., Esseh, K., Tchacondo, T., Batawila, K., Wateba, M. I., Ouro-Djeri, E., Gbeassor, M. Etude ethnopharmacologique des plantes utilisées dans la préparation des phytomédicaments extemporanés à Tomety-Kondji, canton riverain au Parc National de Togodo-Sud du Togo. International Journal of Chemical and Biological Sciences, 2022, 16(3), 967–991.
[10] Bothon, F. T. D., Moustapha, M., Bogninou, S. G., Dossa, C. P. A., Yehouenou, B., Medoatinsa, S. E., Noudogbessi, J. P., Avlessi, F., Sohounhloué, D. C. K. Chemical Characterization and Biological Activities of Newbouldia laevis and Pterocarpus santalinoides Leaves. Bulletin of Environment, Pharmacology and Life Sciences, 2014, 3(11), 9-15.
[11] Sidi, I. Y. M. S., Alowanou, G. G., Tchétan, E., Aminou, M. Y., Hounzangbé-Adoté, S. M., Babatoundé, S. Effets de la Digestion Gastrique sur les Propriétés Anthelminthiques de Zanthoxylum zanthoxyloides (Lam.) Zepernick & Timlerto et de Newbouldia laevis (P. Beauv.) Sur Haemonchus contortus. European Scientific Journal, 2017, 13(24), 204.
[12] Singh, O. P., Hasker, E., Sacks, D., Boelaert, M., Sundar, S. Asymptomatic Leishmania Infection: A New Challenge for Leishmania Control. Clinical Infectious Diseases, 2014, 58 (10), 1424–1429.
[13] Bailly, C. Traditional Uses, Pharmacology and Phytochemistry of the Medicinal Plant Flueggea virosa (Roxb. ex Willd.) Royle. Future Pharmacology, 2024, 4(1), 77-102.
[14] Peng, Y., Zeng, N., Yao, Q., Peng C., Sheng, W., Li, B., Wang, W. A Review of the Medicinal Uses, Phytochemistry and Pharmacology of Genus Flueggea. Current Chinese Science, 2023, 3(3), 213-241.
[15] Tabuti, J. R. S. Flueggea virosa (Roxb. ex Willd.) Voigt. In Plant Resources of Tropical Africa 11(1): Medicinal Plants 1; Schmelzer, G. H., Gurib-Fakim, A., Eds., Prota Foundation: Wageningen, The Netherlands, 2008, 305-308.
[16] Brüssow H. The antibiotic resistance crisis and the development of new antibiotics. Microbial biotechnology, 2024, 17(7): e14510.
[17] Houghton, P. J. and Raman, A. Laboratory Handbook for Fractionation of Natural Extracts. Chapman and Hall, London, New York, 1998, 199 p., 208p.
[18] Kpadonou-Kpoviessi, B., Noudamadjo, A., Goueti, B., Atchade, B., Toukam, P. D., Gbenou, J., Glinma, B., Kpoviessi, S. Phytochemical Screening, Investigation of the Antisalmonella, Antishigella, and Antioxidant Properties of the Leaves of Rauvolfia vomitoria Afzel. Journal of Pure and Applied Chemistry Research, 2024, 13(1), 63–71.
[19] Wayne, P. A. Clinical and Laboratory Standards Institute (2015). Performance Standards for Antimicrobial Susceptibility Testing, 25th Informational Supplement. CLSI Document M100-S25.
[20] Kuete, V., Efferth, T. Cameeroonian Medicinal Plants: Pharmacology and Derived Natural Products. Frontiers in Pharmacology, 2010, 123.
[21] Oghenemaro, E. F., Oise, I. E., Cynthia, D. The Effects of Securinega virosa Leaves on Methicillin-Resistant Staphylococcus Aureus (MRSA). International Journal of Pharmaceutical Research and Allied Sciences, 2021, 10(2), 29–34.
[22] Thiombiano, H. M., Bangou, M. J., Nacoulma, A. P., Ouoba, B., Lema, A., Coulidiati, T. H., Ouoba, H. Y., Ouedraogo, G. A. Ethnobotanical Survey on Medicinal Plants Used in Burkina Faso in the Treatment of Breast Cancer, Phytochemistry and Antioxidant Activities: Euphorbia poissonii Pax and Flueggea virosa (Willd.) Voigt. (Euphorbiaceae). African Journal of Biology and Medical Research, 2022, 5(1), 1–16.
[23] Udeozo, I. P, Nwaka. Andrew C., Ugwu Okechukwu P. C., Akogwu M. Anti-Inflammatory, Phytochemical and Acute Toxicity Study of the Flower Extract of Newbouldia laevis. International Journal of Current Microbiology and Applied Sciences, 2014, 3(3), 1029–1035
[24] Usman, H., Osuji, J. Phytochemical And In Vitro Antimicrobial Assay Of The Leaf Extract Of Newbouldia laevis. African Journal of Traditional, Complementary and Alternative Medicines, 2008, 4(4), 476.
[25] Tinnèlo, S., Tidiane, K., Abdoulaye, T., Souleymane, M., Claude, K. A. L., Adama, C. Phytochemical Screening and Effects on Spermatogenesis of Extracts from Leaves of Flueggea virosa (Roxb, Ex Willd.) Royle and Heliotropium indicum L., Two Plants Used against Infertility in North of Ivory Cost. Journal of Phytopharmacology, 2024, 13(1), 37–42.
[26] Traoré, K., Haidara, M., Denou, A., Kanadjigui, F., Sogoba, M. N., Diarra, B., Maiga, S., Sanogo, R. Criblage Phytochimique et Activités Biologiques de Quatre Plantes Utilisées au Mali dans la Prise en Charge du Paludisme Chez Les Enfants. European Scientific Journal, 2019, 15(6).
[27] Ali, B. H. and Al-Wabel, N. A. Flueggea virosa: A Review of Its Phytochemistry and Pharmacological Potential. Pharmacognosy Reviews, 2015, 9(17), 46–53.
[28] Dickson, R. A., Houghton, P. J., Hylands, P. J., Gibbons, S. Antimicrobial, Resistance-Modifying Effects, Antioxidant and Free Radical Scavenging Activities of Mezoneuron benthamianum Baill., Securinega virosa Roxb. &Wlld. And Microglossa pyrifolia Lam. Phytotherapy Research, 2006, 20 (1), 41-45.
[29] Osuagwu, G. G. E., Akomas, C. Antimicrobial activity of the leaves of three species of Nigerian Pterocarpus (Jacq.). International Journal of Medicinal and Aromatic Plants, 2013, 3, 178-183.
[30] Okagu, I. U., Ndefo, J. N., Agbo, M. O. Trado-Medical uses, Chemical Constituents and Biological Activities of Newbouldia laevis (Bignoniaceae): A Review. Pharmaceutical Sciences, 2021,
Cite This Article
  • APA Style

    Amandine, N., Bénédicta, K., Bienvenu, G., Basile, G., Blandine, K., et al. (2025). Phytochemical Screening and Antimicrobial Properties of Leaf Extracts from Newbouldia laevis (P. Beauv) and Flueggea virosa (Roxb. ex Willd.). Science Journal of Chemistry, 13(2), 33-40. https://doi.org/10.11648/j.sjc.20251302.11

    Copy | Download

    ACS Style

    Amandine, N.; Bénédicta, K.; Bienvenu, G.; Basile, G.; Blandine, K., et al. Phytochemical Screening and Antimicrobial Properties of Leaf Extracts from Newbouldia laevis (P. Beauv) and Flueggea virosa (Roxb. ex Willd.). Sci. J. Chem. 2025, 13(2), 33-40. doi: 10.11648/j.sjc.20251302.11

    Copy | Download

    AMA Style

    Amandine N, Bénédicta K, Bienvenu G, Basile G, Blandine K, et al. Phytochemical Screening and Antimicrobial Properties of Leaf Extracts from Newbouldia laevis (P. Beauv) and Flueggea virosa (Roxb. ex Willd.). Sci J Chem. 2025;13(2):33-40. doi: 10.11648/j.sjc.20251302.11

    Copy | Download

  • @article{10.11648/j.sjc.20251302.11,
      author = {Noudamadjo Amandine and Kpadonou-Kpoviessi Bénédicta and Glinma Bienvenu and Goueti Basile and Kampa-Kuemkon Blandine and Gbaguidi Ahokanou Fernand and Kpoviessi Dossou Sika Salomé},
      title = {Phytochemical Screening and Antimicrobial Properties of Leaf Extracts from Newbouldia laevis (P. Beauv) and Flueggea virosa (Roxb. ex Willd.)
    },
      journal = {Science Journal of Chemistry},
      volume = {13},
      number = {2},
      pages = {33-40},
      doi = {10.11648/j.sjc.20251302.11},
      url = {https://doi.org/10.11648/j.sjc.20251302.11},
      eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.sjc.20251302.11},
      abstract = {Using plants to treat human diseases is very old and has evolved throughout human history. Flueggea virosa and Newbouldia laevis are two plant species acclimatized in Benin and used in Africa to treat several diseases such as malaria, liver diseases; fever, migraine, diarrhea, dysentery, intestinal worms, diabetes, sexually transmitted diseases, etc. In this work, we studied methanolic and hydroethanolic leaf extracts from those species. Phytochemical screening was determined by the Hounton and Raman methods, and the antimicrobial activity of the leaf extracts was evaluated by the microdilution method. The antimicrobial properties of the leaf extracts were examined on five bacteria strains. The phytochemical analysis revealed the presence of alkaloids, polyphenols, tannins, flavonoids, anthocyanins, coumarins, mucilages, reducing compounds, and bound anthracene derivatives (O-heterosides and C-heterosides). Quinonine derivatives were absent in the leaves of Flueggea virosa, but present in the leaves of Newbouldia laevis. In addition, the leaves of Flueggea virosa contained saponosides, triterpenoids compared to those of Newbouldia laevis. Moreover, Flueggea virosa leaves enclosed no cardenolides, cyanogenic derivatives as well as, free leuco-anthocyanins and anthracene derivatives. Evaluation of antimicrobial activity in the five strains included in this study showed better results (minimum inhibitory concentrations between 31.2 and 1000 μg/mL), specifically with the methanolic extract from Flueggea virosa leaves that showed a Minimum Inhibitory Concentration (MIC) equal to 31.2 μg/mL against the reference strain of Staphylococcus aureus ATCC 12600. Among the two plants, Flueggea virosa extracts showed more interesting antimicrobial activity then those of Newbouldia laevis on strains.
    },
     year = {2025}
    }
    

    Copy | Download

  • TY  - JOUR
    T1  - Phytochemical Screening and Antimicrobial Properties of Leaf Extracts from Newbouldia laevis (P. Beauv) and Flueggea virosa (Roxb. ex Willd.)
    
    AU  - Noudamadjo Amandine
    AU  - Kpadonou-Kpoviessi Bénédicta
    AU  - Glinma Bienvenu
    AU  - Goueti Basile
    AU  - Kampa-Kuemkon Blandine
    AU  - Gbaguidi Ahokanou Fernand
    AU  - Kpoviessi Dossou Sika Salomé
    Y1  - 2025/04/02
    PY  - 2025
    N1  - https://doi.org/10.11648/j.sjc.20251302.11
    DO  - 10.11648/j.sjc.20251302.11
    T2  - Science Journal of Chemistry
    JF  - Science Journal of Chemistry
    JO  - Science Journal of Chemistry
    SP  - 33
    EP  - 40
    PB  - Science Publishing Group
    SN  - 2330-099X
    UR  - https://doi.org/10.11648/j.sjc.20251302.11
    AB  - Using plants to treat human diseases is very old and has evolved throughout human history. Flueggea virosa and Newbouldia laevis are two plant species acclimatized in Benin and used in Africa to treat several diseases such as malaria, liver diseases; fever, migraine, diarrhea, dysentery, intestinal worms, diabetes, sexually transmitted diseases, etc. In this work, we studied methanolic and hydroethanolic leaf extracts from those species. Phytochemical screening was determined by the Hounton and Raman methods, and the antimicrobial activity of the leaf extracts was evaluated by the microdilution method. The antimicrobial properties of the leaf extracts were examined on five bacteria strains. The phytochemical analysis revealed the presence of alkaloids, polyphenols, tannins, flavonoids, anthocyanins, coumarins, mucilages, reducing compounds, and bound anthracene derivatives (O-heterosides and C-heterosides). Quinonine derivatives were absent in the leaves of Flueggea virosa, but present in the leaves of Newbouldia laevis. In addition, the leaves of Flueggea virosa contained saponosides, triterpenoids compared to those of Newbouldia laevis. Moreover, Flueggea virosa leaves enclosed no cardenolides, cyanogenic derivatives as well as, free leuco-anthocyanins and anthracene derivatives. Evaluation of antimicrobial activity in the five strains included in this study showed better results (minimum inhibitory concentrations between 31.2 and 1000 μg/mL), specifically with the methanolic extract from Flueggea virosa leaves that showed a Minimum Inhibitory Concentration (MIC) equal to 31.2 μg/mL against the reference strain of Staphylococcus aureus ATCC 12600. Among the two plants, Flueggea virosa extracts showed more interesting antimicrobial activity then those of Newbouldia laevis on strains.
    
    VL  - 13
    IS  - 2
    ER  - 

    Copy | Download

Author Information
  • Department of Chemistry, Laboratory of Physical Organic Chemistry and Synthesis (LaCOPS), Faculty of Sciences and Technology (FAST) of University of Abomey-Calavi (UAC), Abomey-Calavi, Benin; Department of Biology, Laboratory of Molecular Biology Center (Projet of YaBiNaPA), University of Yaounde I, Yaounde I, Cameroon

  • Department of Chemistry, Laboratory of Physical Organic Chemistry and Synthesis (LaCOPS), Faculty of Sciences and Technology (FAST) of University of Abomey-Calavi (UAC), Abomey-Calavi, Benin

  • Department of Chemistry, Laboratory of Physical Organic Chemistry and Synthesis (LaCOPS), Faculty of Sciences and Technology (FAST) of University of Abomey-Calavi (UAC), Abomey-Calavi, Benin

  • Department of Chemistry, Laboratory of Physical Organic Chemistry and Synthesis (LaCOPS), Faculty of Sciences and Technology (FAST) of University of Abomey-Calavi (UAC), Abomey-Calavi, Benin

  • Department of Biology, Laboratory of Molecular Biology Center (Projet of YaBiNaPA), University of Yaounde I, Yaounde I, Cameroon

  • Department of Chemistry, Laboratory of Physical Organic Chemistry and Synthesis (LaCOPS), Faculty of Sciences and Technology (FAST) of University of Abomey-Calavi (UAC), Abomey-Calavi, Benin

  • Department of Chemistry, Laboratory of Physical Organic Chemistry and Synthesis (LaCOPS), Faculty of Sciences and Technology (FAST) of University of Abomey-Calavi (UAC), Abomey-Calavi, Benin